5 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
Follow ipragliflozin: new trials by email Literature Review of ipragliflozin trials Research Report on ipragliflozin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes Mellitus Placebo, ASP1941 - Type 1 Diabetes Mellitus | Phase 2 | Completed | Astellas Pharma Inc | 43 | 2015-09-01 | 2024-11-12 |
| A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes Mellitus ipragliflozin, Placebo, Metformin - Type 2 Diabetes Mellitus | Phase 2 | Completed | Astellas Pharma Inc | 343 | 2010-04-06 | 2025-05-22 |
| A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus ipragliflozin, Metformin, Placebo - Diabetes Mellitus, Type 2 | Phase 2 | Completed | Astellas Pharma Inc | 412 | 2010-03-03 | 2025-05-22 |
| A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus. ASP1941, Placebo - Diabetes Mellitus, Type 2 | Phase 2 | Completed | Astellas Pharma Inc | 61 | 2008-10-23 | 2024-11-14 |
| A Study of ASP1941 in Participants With Type 2 Diabetes Mellitus ipragliflozin, Placebo - Diabetes Mellitus | Phase 2 | Completed | Astellas Pharma Inc | 361 | 2008-03-26 | 2024-11-12 |
Diabetes Mellitus, Type 2 (4) · Diabetes Mellitus (3) · Diabetes Mellitus, Type 1 (1)
United States (3) · Japan (2) · Colombia (1) · Hungary (1) · India (1) · Italy (1) · Mexico (1) · Philippines (1) · Poland (1) · Romania (1) · United Kingdom (1)
PMID 31606880, PMID 23276620, PMID 25411597, PMID 32839028
2009 (1)